Health Care & Life Sciences » Pharmaceuticals | Aspen Pharmacare Holdings Ltd.

Aspen Pharmacare Holdings Ltd. | Income Statement

Fiscal year is July-June. All values ZAR Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
19,308
29,515
36,127
35,600
41,200
42,596
Cost of Goods Sold (COGS) incl. D&A
10,333
16,183
19,492
18,400
21,300
21,780
Gross Income
8,975
13,332
16,634
17,200
19,900
20,816
SG&A Expense
3,479
6,054
8,167
8,500
9,300
10,406
EBIT
5,239
7,221
8,233
9,300
10,600
10,410
Unusual Expense
224
573
327
1,500
2,500
1,314
Non Operating Income/Expense
36
919
225
100
200
1
Interest Expense
842
1,456
1,956
2,100
2,000
2,093
Pretax Income
4,489
6,357
6,538
6,100
6,200
7,345
Income Tax
975
1,351
1,339
1,800
1,100
1,385
Consolidated Net Income
3,514
5,006
5,199
4,300
5,100
6,011
Net Income
3,520
5,008
5,201
4,300
5,100
6,010
Net Income After Extraordinaries
3,520
5,008
5,201
4,300
5,100
6,010
Net Income Available to Common
3,520
5,008
5,201
4,300
5,100
6,010
EPS (Basic)
7.73
10.98
11.40
9.42
11.17
13.17
Basic Shares Outstanding
455
456
456
456
456
457
EPS (Diluted)
7.72
10.98
11.40
9.42
11.17
13.17
Diluted Shares Outstanding
456
456
456
457
456
457
EBITDA
5,789
8,044
9,273
10,500
11,900
11,782
Other Operating Expense
257
58
234
600
-
-
Non-Operating Interest Income
281
246
363
300
300
343
Minority Interest Expense
6
2
2
-
-
1

About Aspen Pharmacare Holdings

View Profile
Address
Aspen Place, 9 Rydall Vale Park
Durban NL 4019
South Africa
Employees -
Website http://www.aspenpharma.com
Updated 07/08/2019
Aspen Pharmacare Holdings Ltd. engages in the manufacture and supply of branded and generic pharmaceutical products. The firm operates through the following segments: Commercial Pharmaceuticals, Nutritionals, and Manufacturing. The Commercial Pharmaceuticals segment comprises of the Anaesthetic; Thrombosis; High Potency and Cytotoxics; and Other Commercial Pharmaceutical Brands.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.